Major depressive disorder, recurrent episode Recruiting Phase 2 Trials for Psilocybin (DB11664)

Back to Major depressive disorder, recurrent episode

Also known as: Depression, Treatment Resistant / Treatment-resistant Depression (TRD) / Resistant Depression, Treatment / Treatment-Resistant Depression / Treatment Resistant Depression (TRD) / Treatment Resistant Depression / Major depressive disorder, recurrent, unspecified / Recurrent major depressive episodes (disorder) / Major depressive disorder, recurrent / Recurrent major depression (disorder) / Treatment resistant depression (disorder) / Depressive Disorder, Treatment-Resistant / Major depressive disorder, single episode, unspecified / Major depressive disorder / Major depressive illness / Major depressive disorder (disorder) / Major depression / Major depressive disorder NOS / Depressive Disorder, Major / Depressive state / Depression NOS / Depressed state / Depression / Depression mental

Indication	Status	Phase
DBCOND0089536 (Major depressive disorder, recurrent episode)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT06378229	Psilocybin for Hospitalized Patients with Treatment-resistant Depression	Treatment	Psilocybin (DB11664)
NCT05383313	Psilocybin Versus Ketamine in Treatment-Resistant Depression	Health Services Research	Ketamine (DB01221) Midazolam (DB00683) Psilocybin (DB11664)
NCT05710237	Does Psilocybin Require Psychedelic Effects to Treat Depression?	Treatment	Psilocybin (DB11664) Risperidone (DB00734)
NCT05220410	The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation	Treatment	Psilocybin (DB11664)
NCT06341426	Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin	Treatment	Psilocybin (DB11664)